
VIR BIOTECHNOLOGY INC
VIRNASDAQ๐ #2031 by market capEarnings Nov 4US Equity
$9.06โฒ $0.13 (+1.46%)
Live1hโฒ 0.2%
24hโฒ 1.5%
7dโผ 0.8%
14dโฒ 4.7%
30dโผ 6.8%
1yโฒ 108.3%
๐ฆMarket Cap
$1.53B
Small Cap
๐Revenue Growth (YoY)
+1496.1%
High Growth
๐Gross Margin
100.0%
High
๐ตFCF Margin
40.7%
Strong
โ๏ธP/S Ratio
4.9x
Fair
Otter Score
57
Weak
Earnings
Q3 ยท 2026Reported 2026-08-05Earnings Per Share
Actual
0.47
Expected
0.33
beat
+41.30%
YoY +158.80%
Revenue
Actual
$238.95M
Expected
$135.88M
beat
+75.80%
YoY +19582.50%
Consensus estimates
Recent quarters
Q3 2026
0.47
beat
Q2 2026
-0.85
miss
Q1 2026
-0.31
beat
Q4 2025
-1.17
miss